These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9452999)

  • 1. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.
    Yo Y; Morishita R; Yamamoto K; Tomita N; Kida I; Hayashi S; Moriguchi A; Kato S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Jan; 53(1):50-8. PubMed ID: 9452999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
    Yo Y; Morishita R; Nakamura S; Tomita N; Yamamoto K; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Oct; 54(4):1128-38. PubMed ID: 9767528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.
    Morishita R; Nakamura S; Nakamura Y; Aoki M; Moriguchi A; Kida I; Yo Y; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Diabetes; 1997 Jan; 46(1):138-42. PubMed ID: 8971094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
    Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
    Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
    Matsumoto K; Morishita R; Tomita N; Moriguchi A; Komai N; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human hepatocyte growth factor (HGF), but not rat HGF, elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism.
    Mizuno S; Ikebuchi F; Fukuta K; Kato T; Matsumoto K; Adachi K; Abe T; Nakamura T
    Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):192-201. PubMed ID: 21251050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
    Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
    Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression.
    Liu Y; Centracchio JN; Lin L; Sun AM; Dworkin LD
    Exp Cell Res; 1998 Jul; 242(1):174-85. PubMed ID: 9665815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
    J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.
    Mizuno S; Matsumoto K; Nakamura T
    Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate.
    Biswas P; Roy A; Gong R; Yango A; Tolbert E; Centracchio J; Dworkin LD
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F8-15. PubMed ID: 15583218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways.
    Liu Y; Rajur K; Tolbert E; Dworkin LD
    Kidney Int; 2000 Nov; 58(5):2028-43. PubMed ID: 11044223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
    Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
    Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.
    Matsumoto K; Nakamura T
    Kidney Int; 2001 Jun; 59(6):2023-38. PubMed ID: 11380804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice.
    Mizuno S; Matsumoto K; Kurosawa T; Mizuno-Horikawa Y; Nakamura T
    Kidney Int; 2000 Mar; 57(3):937-48. PubMed ID: 10720947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
    Bessho K; Mizuno S; Matsumoto K; Nakamura T
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
    Taniyama Y; Morishita R; Nakagami H; Moriguchi A; Sakonjo H; Shokei-Kim ; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Circulation; 2000 Jul; 102(2):246-52. PubMed ID: 10889138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.